These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 3354253

  • 21. Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs.
    Shuai L, Wang X, Wen Z, Ge J, Wang J, Zhao D, Bu Z.
    Antiviral Res; 2017 Oct; 146():36-44. PubMed ID: 28822816
    [Abstract] [Full Text] [Related]

  • 22. Cross-protection of mice against a global spectrum of rabies virus variants.
    Lodmell DL, Smith JS, Esposito JJ, Ewalt LC.
    J Virol; 1995 Aug; 69(8):4957-62. PubMed ID: 7609065
    [Abstract] [Full Text] [Related]

  • 23. Antigenic variations of recent street rabies virus.
    Wang W, Ma J, Nie J, Li J, Cao S, Wang L, Yu C, Huang W, Li Y, Yu Y, Liang M, Zirkle B, Chen XS, Li X, Kong W, Wang Y.
    Emerg Microbes Infect; 2019 Aug; 8(1):1584-1592. PubMed ID: 31682199
    [Abstract] [Full Text] [Related]

  • 24. Effect of strain differences on the potency testing of rabies vaccines in mice.
    Blancou J, Aubert MF, Cain E, Selve M, Thraenhart O, Bruckner L.
    J Biol Stand; 1989 Jul; 17(3):259-66. PubMed ID: 2793877
    [Abstract] [Full Text] [Related]

  • 25. Two potential recombinant rabies vaccines expressing canine parvovirus virion protein 2 induce immunogenicity to canine parvovirus and rabies virus.
    Luo J, Shi H, Tan Y, Niu X, Long T, Zhao J, Tian Q, Wang Y, Chen H, Guo X.
    Vaccine; 2016 Aug 17; 34(37):4392-8. PubMed ID: 27449079
    [Abstract] [Full Text] [Related]

  • 26. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.
    Shuai L, Feng N, Wang X, Ge J, Wen Z, Chen W, Qin L, Xia X, Bu Z.
    Antiviral Res; 2015 Sep 17; 121():9-15. PubMed ID: 26093157
    [Abstract] [Full Text] [Related]

  • 27. Virus-Like Vesicles Based on Semliki Forest Virus-Containing Rabies Virus Glycoprotein Make a Safe and Efficacious Rabies Vaccine Candidate in a Mouse Model.
    Zhang C, Tian Y, Chen C, Wang Z, Pei J, Lin C, Zhou M, Fu ZF, Zhao L.
    J Virol; 2021 Sep 27; 95(20):e0079021. PubMed ID: 34346765
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Recombinant canine distemper virus serves as bivalent live vaccine against rabies and canine distemper.
    Wang X, Feng N, Ge J, Shuai L, Peng L, Gao Y, Yang S, Xia X, Bu Z.
    Vaccine; 2012 Jul 20; 30(34):5067-72. PubMed ID: 22698451
    [Abstract] [Full Text] [Related]

  • 30. Epidemiologic analysis of antigenic variations of street rabies virus: detection by monoclonal antibodies.
    Sureau P, Rollin P, Wiktor TJ.
    Am J Epidemiol; 1983 May 20; 117(5):605-9. PubMed ID: 6342369
    [Abstract] [Full Text] [Related]

  • 31. Production in Vero cells of an inactivated rabies vaccine from strain FRV/K for animal and human use.
    el-Karamany RM.
    Acta Virol; 1987 Aug 20; 31(4):321-8. PubMed ID: 2892381
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Cell-mediated immune response to rabies virus in dogs following vaccination and challenge.
    Gerber JD, Sharpee RL, Swieczkowski TC, Beckenhauer WH.
    Vet Immunol Immunopathol; 1985 May 20; 9(1):13-22. PubMed ID: 4024449
    [Abstract] [Full Text] [Related]

  • 34. Glycoprotein from street rabies virus BD06 induces early and robust immune responses when expressed from a non-replicative adenovirus recombinant.
    Wang S, Sun C, Zhang S, Zhang X, Liu Y, Wang Y, Zhang F, Wu X, Hu R.
    Arch Virol; 2015 Sep 20; 160(9):2315-23. PubMed ID: 26143474
    [Abstract] [Full Text] [Related]

  • 35. Efficacy of rabies vaccines against Duvenhage virus isolated from European house bats (Eptesicus serotinus), classic rabies and rabies-related viruses.
    Fekadu M, Shaddock JH, Sanderlin DW, Smith JS.
    Vaccine; 1988 Dec 20; 6(6):533-9. PubMed ID: 3245296
    [Abstract] [Full Text] [Related]

  • 36. [The influence of thymus on mouse resistance against rabies before and after vaccination (author's transl)].
    Andral L, Blancou J, Aubert M, Thiery G.
    Ann Microbiol (Paris); 1979 Apr 20; 130A(3):355-63. PubMed ID: 484993
    [Abstract] [Full Text] [Related]

  • 37. Efficacy of inactivated tissue culture rabies vaccine in dogs.
    Strating A, Bunn TO, Goff MT, Phillips CE.
    J Am Vet Med Assoc; 1975 Nov 01; 167(9):809-12. PubMed ID: 1237485
    [Abstract] [Full Text] [Related]

  • 38. Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies.
    Zhang S, Liu Y, Fooks AR, Zhang F, Hu R.
    Vaccine; 2008 Jan 17; 26(3):345-50. PubMed ID: 18083277
    [Abstract] [Full Text] [Related]

  • 39. Immunogenic and antigenic activity of an experimental oral rabies vaccine prepared from the strain Vnukovo-32/107.
    Svrcek S, Durove A, Ondrejka R, Závadová J, Süliová J, Benísek Z, Vrtiak OJ, Feketeová J, Mad'ar M.
    Vet Med (Praha); 1995 Mar 17; 40(3):87-96. PubMed ID: 7762124
    [Abstract] [Full Text] [Related]

  • 40. Antigenic characterisation of virus isolates from vaccinated dogs dying of rabies.
    Aghomo HO, Rupprecht CE.
    Trop Anim Health Prod; 1990 Nov 17; 22(4):275-80. PubMed ID: 2288013
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.